Our global Business Development team helps put better health within reach, every day by in-licensing and acquiring innovative, NDA/ANDA, and generic high-quality medicines and making them accessible to the people who need them. Also, we transform cutting edge science into innovative solutions by providing access to Contract Manufacturing Organisations (CMO) businesses globally as we continue to transform people’s lives, for a healthier world, wherever we are.
Latest news
Hikma assigned investment grade status from Fitch Ratings
22 October 2020